We identified that 11% of metastatic esophageal SCC had PIK3CA mutations in exon 9 (E542K, E545K) and exon 20 (H1047R, L) and that 1% of the patients harbored BRAF V600E mutations. Here, PIK3CA is linked to esophageal squamous cell carcinoma.